The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Topical Hemostatic Agents Market Research Report 2025
Synopsis
Topical hemostatic agents are important adjuncts to reduce blood loss after cardiac surgery and can have a role in reducing both “surgical” and “nonsurgical bleeding.” There are many topical hemostatic agents to choose from, and with several new products in this field being approved for use in the last few years,
The global Topical Hemostatic Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Topical Hemostatic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Topical Hemostatic Agents.
Report Scope
The Topical Hemostatic Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Topical Hemostatic Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Topical Hemostatic Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Segment by Type
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Segment by Application
Hospitals
Surgical Centers
Nursing Homes
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Topical Hemostatic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Topical Hemostatic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Topical hemostatic agents are important adjuncts to reduce blood loss after cardiac surgery and can have a role in reducing both “surgical” and “nonsurgical bleeding.” There are many topical hemostatic agents to choose from, and with several new products in this field being approved for use in the last few years,
The global Topical Hemostatic Agents market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Topical Hemostatic Agents, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Topical Hemostatic Agents.
Report Scope
The Topical Hemostatic Agents market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Topical Hemostatic Agents market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Topical Hemostatic Agents manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ethicon
Pfizer
Baxter International
C. R. Bard
The Medicines Company
Anika Therapeutics
Advanced Medical Solutions
Integra LifeSciences
B Braun Melsungen
Gelita Medical
Equimedical
Vascular Solutions
Marine Polymer Technologies
Segment by Type
Gelation Sponge
Oxidized Regenerated Cellulose Based Hemostats
Others
Segment by Application
Hospitals
Surgical Centers
Nursing Homes
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Topical Hemostatic Agents manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Topical Hemostatic Agents in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Topical Hemostatic Agents Market Overview
1.1 Product Overview and Scope of Topical Hemostatic Agents
1.2 Topical Hemostatic Agents Segment by Type
1.2.1 Global Topical Hemostatic Agents Market Value Comparison by Type (2024-2030)
1.2.2 Gelation Sponge
1.2.3 Oxidized Regenerated Cellulose Based Hemostats
1.2.4 Others
1.3 Topical Hemostatic Agents Segment by Application
1.3.1 Global Topical Hemostatic Agents Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Surgical Centers
1.3.4 Nursing Homes
1.4 Global Topical Hemostatic Agents Market Size Estimates and Forecasts
1.4.1 Global Topical Hemostatic Agents Revenue 2019-2030
1.4.2 Global Topical Hemostatic Agents Sales 2019-2030
1.4.3 Global Topical Hemostatic Agents Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Topical Hemostatic Agents Market Competition by Manufacturers
2.1 Global Topical Hemostatic Agents Sales Market Share by Manufacturers (2019-2024)
2.2 Global Topical Hemostatic Agents Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Topical Hemostatic Agents Average Price by Manufacturers (2019-2024)
2.4 Global Topical Hemostatic Agents Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Topical Hemostatic Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Topical Hemostatic Agents, Product Type & Application
2.7 Topical Hemostatic Agents Market Competitive Situation and Trends
2.7.1 Topical Hemostatic Agents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Topical Hemostatic Agents Players Market Share by Revenue
2.7.3 Global Topical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Topical Hemostatic Agents Retrospective Market Scenario by Region
3.1 Global Topical Hemostatic Agents Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Topical Hemostatic Agents Global Topical Hemostatic Agents Sales by Region: 2019-2030
3.2.1 Global Topical Hemostatic Agents Sales by Region: 2019-2024
3.2.2 Global Topical Hemostatic Agents Sales by Region: 2025-2030
3.3 Global Topical Hemostatic Agents Global Topical Hemostatic Agents Revenue by Region: 2019-2030
3.3.1 Global Topical Hemostatic Agents Revenue by Region: 2019-2024
3.3.2 Global Topical Hemostatic Agents Revenue by Region: 2025-2030
3.4 North America Topical Hemostatic Agents Market Facts & Figures by Country
3.4.1 North America Topical Hemostatic Agents Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Topical Hemostatic Agents Sales by Country (2019-2030)
3.4.3 North America Topical Hemostatic Agents Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Topical Hemostatic Agents Market Facts & Figures by Country
3.5.1 Europe Topical Hemostatic Agents Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Topical Hemostatic Agents Sales by Country (2019-2030)
3.5.3 Europe Topical Hemostatic Agents Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Topical Hemostatic Agents Market Facts & Figures by Country
3.6.1 Asia Pacific Topical Hemostatic Agents Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Topical Hemostatic Agents Sales by Country (2019-2030)
3.6.3 Asia Pacific Topical Hemostatic Agents Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Topical Hemostatic Agents Market Facts & Figures by Country
3.7.1 Latin America Topical Hemostatic Agents Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Topical Hemostatic Agents Sales by Country (2019-2030)
3.7.3 Latin America Topical Hemostatic Agents Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Topical Hemostatic Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Topical Hemostatic Agents Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Topical Hemostatic Agents Sales by Country (2019-2030)
3.8.3 Middle East and Africa Topical Hemostatic Agents Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Topical Hemostatic Agents Sales by Type (2019-2030)
4.1.1 Global Topical Hemostatic Agents Sales by Type (2019-2024)
4.1.2 Global Topical Hemostatic Agents Sales by Type (2025-2030)
4.1.3 Global Topical Hemostatic Agents Sales Market Share by Type (2019-2030)
4.2 Global Topical Hemostatic Agents Revenue by Type (2019-2030)
4.2.1 Global Topical Hemostatic Agents Revenue by Type (2019-2024)
4.2.2 Global Topical Hemostatic Agents Revenue by Type (2025-2030)
4.2.3 Global Topical Hemostatic Agents Revenue Market Share by Type (2019-2030)
4.3 Global Topical Hemostatic Agents Price by Type (2019-2030)
5 Segment by Application
5.1 Global Topical Hemostatic Agents Sales by Application (2019-2030)
5.1.1 Global Topical Hemostatic Agents Sales by Application (2019-2024)
5.1.2 Global Topical Hemostatic Agents Sales by Application (2025-2030)
5.1.3 Global Topical Hemostatic Agents Sales Market Share by Application (2019-2030)
5.2 Global Topical Hemostatic Agents Revenue by Application (2019-2030)
5.2.1 Global Topical Hemostatic Agents Revenue by Application (2019-2024)
5.2.2 Global Topical Hemostatic Agents Revenue by Application (2025-2030)
5.2.3 Global Topical Hemostatic Agents Revenue Market Share by Application (2019-2030)
5.3 Global Topical Hemostatic Agents Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Ethicon
6.1.1 Ethicon Corporation Information
6.1.2 Ethicon Description and Business Overview
6.1.3 Ethicon Topical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Ethicon Topical Hemostatic Agents Product Portfolio
6.1.5 Ethicon Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Topical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Topical Hemostatic Agents Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Baxter International
6.3.1 Baxter International Corporation Information
6.3.2 Baxter International Description and Business Overview
6.3.3 Baxter International Topical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Baxter International Topical Hemostatic Agents Product Portfolio
6.3.5 Baxter International Recent Developments/Updates
6.4 C. R. Bard
6.4.1 C. R. Bard Corporation Information
6.4.2 C. R. Bard Description and Business Overview
6.4.3 C. R. Bard Topical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 C. R. Bard Topical Hemostatic Agents Product Portfolio
6.4.5 C. R. Bard Recent Developments/Updates
6.5 The Medicines Company
6.5.1 The Medicines Company Corporation Information
6.5.2 The Medicines Company Description and Business Overview
6.5.3 The Medicines Company Topical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.5.4 The Medicines Company Topical Hemostatic Agents Product Portfolio
6.5.5 The Medicines Company Recent Developments/Updates
6.6 Anika Therapeutics
6.6.1 Anika Therapeutics Corporation Information
6.6.2 Anika Therapeutics Description and Business Overview
6.6.3 Anika Therapeutics Topical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Anika Therapeutics Topical Hemostatic Agents Product Portfolio
6.6.5 Anika Therapeutics Recent Developments/Updates
6.7 Advanced Medical Solutions
6.6.1 Advanced Medical Solutions Corporation Information
6.6.2 Advanced Medical Solutions Description and Business Overview
6.6.3 Advanced Medical Solutions Topical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Advanced Medical Solutions Topical Hemostatic Agents Product Portfolio
6.7.5 Advanced Medical Solutions Recent Developments/Updates
6.8 Integra LifeSciences
6.8.1 Integra LifeSciences Corporation Information
6.8.2 Integra LifeSciences Description and Business Overview
6.8.3 Integra LifeSciences Topical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Integra LifeSciences Topical Hemostatic Agents Product Portfolio
6.8.5 Integra LifeSciences Recent Developments/Updates
6.9 B Braun Melsungen
6.9.1 B Braun Melsungen Corporation Information
6.9.2 B Braun Melsungen Description and Business Overview
6.9.3 B Braun Melsungen Topical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.9.4 B Braun Melsungen Topical Hemostatic Agents Product Portfolio
6.9.5 B Braun Melsungen Recent Developments/Updates
6.10 Gelita Medical
6.10.1 Gelita Medical Corporation Information
6.10.2 Gelita Medical Description and Business Overview
6.10.3 Gelita Medical Topical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Gelita Medical Topical Hemostatic Agents Product Portfolio
6.10.5 Gelita Medical Recent Developments/Updates
6.11 Equimedical
6.11.1 Equimedical Corporation Information
6.11.2 Equimedical Topical Hemostatic Agents Description and Business Overview
6.11.3 Equimedical Topical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Equimedical Topical Hemostatic Agents Product Portfolio
6.11.5 Equimedical Recent Developments/Updates
6.12 Vascular Solutions
6.12.1 Vascular Solutions Corporation Information
6.12.2 Vascular Solutions Topical Hemostatic Agents Description and Business Overview
6.12.3 Vascular Solutions Topical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Vascular Solutions Topical Hemostatic Agents Product Portfolio
6.12.5 Vascular Solutions Recent Developments/Updates
6.13 Marine Polymer Technologies
6.13.1 Marine Polymer Technologies Corporation Information
6.13.2 Marine Polymer Technologies Topical Hemostatic Agents Description and Business Overview
6.13.3 Marine Polymer Technologies Topical Hemostatic Agents Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Marine Polymer Technologies Topical Hemostatic Agents Product Portfolio
6.13.5 Marine Polymer Technologies Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Topical Hemostatic Agents Industry Chain Analysis
7.2 Topical Hemostatic Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Topical Hemostatic Agents Production Mode & Process
7.4 Topical Hemostatic Agents Sales and Marketing
7.4.1 Topical Hemostatic Agents Sales Channels
7.4.2 Topical Hemostatic Agents Distributors
7.5 Topical Hemostatic Agents Customers
8 Topical Hemostatic Agents Market Dynamics
8.1 Topical Hemostatic Agents Industry Trends
8.2 Topical Hemostatic Agents Market Drivers
8.3 Topical Hemostatic Agents Market Challenges
8.4 Topical Hemostatic Agents Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
